Covenants: Financial Covenants: LTV ratio ≤ 50% & ICR ratio ≥ 1.8x, suspension of Financial Covenants if no event of default exists and NIH is rated Baa1 stable or above by Moody’s Secured Borrowing Covenants: Secured debt ratio ≤ 20%
Use of Proceeds: The net proceeds will be used by the issuer for general corporate purposes, including the financing of the concurrent tender offer of the €750m 5.875 % 2028 notes (FR001400PIA0) and €650m 4.875% 2028 notes (FR001400EHH1)
Marketing:fixed income investor calls to be scheduled on 01-Sep-26
Global Coordinators: Crédit Agricole CIB (B&D), La Banque Postale, Société Générale
Active Bookrunners: CIC CIB, Crédit Agricole CIB, La Banque Postale, Natixis, Société Générale
ISIN: FR001401ART1
Common Code: 349880792
Target Market: Manufacturer target market is eligible counterparties and professional investors (all distribution channels). No EEA PRIIPs key information document (KID), no disclosure document under the DISC or CCI product summary has been prepared as not available to retail in EEA or the UK.
Timing: Books open, today’s business
Selling Restrictions: As per EMTN Programme
Ownership:Privately owned by the Mulliez family. \
Biz: property investment (Ceetrus) and real estate services (Nhood).
HQ: Puteaux, France.
Advertisement: The Base Prospectus (dated 31-Oct-25), as supplemented on 25-Mar-26 & 25-Aug-26, is available on the websites of the Luxembour